In summary, our results demonstrate that high expression of TβRII in breast cancer cells may be a prognostic marker for breast cancer patients and the deep research is needed to provide useful information for evaluating the effect of TGF-β in the development of breast cancer. This evidence concerns the gene TGFBR2 and breast cancer.